Atea Pharmaceuticals (AVIR) Stock Chart & Stock Price History $3.16 +0.06 (+1.94%) (As of 12/17/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Atea Pharmaceuticals Stock Price Performance 5 Day Performance+7.85%1 Month Performance-0.32%3 Month Performance-20.80%6 Month Performance-9.46%Year-To-Date Performance+3.61%1 Year Performance+3.95% Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. AVIR Stock Chart for Wednesday, December, 18, 2024 AVIR Chart by TradingView Atea Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$3.10$3.16+1.94%$3.17$3.04516,970 shs$266.90 million12/16/2024$2.93$3.10+5.80%$3.24$3.091.59 million shs$261.84 million12/13/2024$2.95$2.93-0.68%$2.97$2.88256,573 shs$247.47 million12/12/2024$2.96$2.95-0.34%$3.08$2.91300,844 shs$249.17 million12/11/2024$2.94$2.96+0.68%$2.99$2.88257,739 shs$250.01 million12/10/2024$3.02$2.94-2.65%$3.03$2.75909,469 shs$248.32 million Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$2.94$3.02+2.72%$3.07$2.89303,118 shs$255.07 million12/06/2024$2.93$2.94+0.34%$2.94$2.87308,388 shs$248.32 million12/05/2024$3.12$2.93-6.09%$3.11$2.86494,670 shs$247.47 million12/04/2024$3.48$3.12-10.34%$3.50$3.11653,126 shs$263.52 million12/03/2024$3.50$3.48-0.57%$3.50$3.45152,755 shs$293.92 million12/02/2024$3.42$3.50+2.34%$3.54$3.38140,741 shs$295.62 million11/29/2024$3.46$3.42-1.16%$3.49$3.34119,282 shs$288.85 million11/28/2024$3.46$3.46$3.50$3.37240,692 shs$292.24 million11/27/2024$3.30$3.46+4.85%$3.50$3.37194,315 shs$292.23 million11/26/2024$3.40$3.30-2.94%$3.40$3.27154,791 shs$278.72 million11/25/2024$3.37$3.40+0.89%$3.48$3.37183,110 shs$287.16 million11/22/2024$3.24$3.37+4.01%$3.39$3.24148,944 shs$284.63 million11/21/2024$3.16$3.24+2.53%$3.26$3.1688,299 shs$273.66 million11/20/2024$3.14$3.16+0.64%$3.16$3.10182,019 shs$266.90 million11/19/2024$3.17$3.14-0.95%$3.17$3.1294,277 shs$265.21 million11/18/2024$3.22$3.17-1.55%$3.32$3.16119,274 shs$267.74 million Related Companies Bicycle Therapeutics Stock Price Chart Avadel Pharmaceuticals Stock Price Chart Collegium Pharmaceutical Stock Price Chart Septerna Stock Price Chart Bicara Therapeutics Stock Price Chart Zymeworks Stock Price Chart Gyre Therapeutics Stock Price Chart Poseida Therapeutics Stock Price Chart Phibro Animal Health Stock Price Chart Nuvation Bio Stock Price Chart Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVIR) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVIR Stock Alerts